Oncology products
In the fight against cancer, having innovative treatments is only one part of success. Our approach focuses on offering a portfolio of cutting-edge oncology products, ensuring that patients have access to safe, effective, and timely therapies to improve their quality of life.
PHARMACEUTICAL FORMS
We work with laboratories that manufacture tablets, capsules, liquids, injectables, and lyophilized powders.
Our Products
Landlords
Cyclophosphamide : Injectable to treat various types of cancer such as lymphomas, leukemias, breast cancer and ovarian cancer.
Ifosfamide : Injectable vial for the treatment of cancers such as sarcomas, testicular cancer, and lymphomas .
Chlorambucil : Tablets for the treatment of chronic lymphocytic leukemia (CLL), Hodgkin and non-Hodgkin lymphoma.
Melphalan : Injectable and Tablets for the treatment of multiple myeloma and advanced ovarian cancer
Antimetabolites
Methotrexate : Injectable and tablets for the treatment of leukemias, lymphomas, breast cancer, lung cancer and also in autoimmune diseases such as rheumatoid arthritis.
5-Fluorouracil (5-FU): Injectable for the treatment of colorectal, gastric, breast, pancreatic and head and neck cancer.
Capecitabine: Tablets for the treatment of colorectal, breast, and gastric cancer. It is an oral form that is converted to 5-FU in the body.
Gemcitabine: Injectable for the treatment of pancreatic, lung, bladder and breast cancer.
Vinca alkaloids
Vincristine : Injectable for the treatment of leukemias, lymphomas, sarcomas and some pediatric tumors such as neuroblastoma.
Vinblastine : Injectable for the treatment of Hodgkin lymphoma, testicular cancer and breast cancer.
Vinorelbine : Injectable and capsules for the treatment of non-small cell lung cancer and advanced breast cancer.
Taxanes
Paclitaxel : Injectable for the treatment of breast, ovarian, non-small cell lung and pancreatic cancer.
Docetaxel : Injectable for the treatment of breast, prostate, non-small cell lung, gastric and head and neck cancers.
Antitumor antibiotics
Doxorubicin : Injectable for the treatment of various types of cancer such as leukemias, lymphomas, breast cancer, ovarian cancer, lung cancer and sarcomas.
Daunorubicin : Injectable for the treatment of leukemias such as acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
Bleomycin : Injectable for the treatment of Hodgkin lymphoma, testicular cancer, head and neck cancer, and skin cancer (squamous cell carcinoma)
Topoisomerase inhibitors
Irinotecan : Injectable for the treatment of metastatic colorectal cancer and other solid tumors such as lung cancer.
Etoposide : Injectable and capsules for the treatment of small cell lung cancer, lymphomas, and testicular cancer.
Topotecan : Injectable and capsules for the treatment of recurrent ovarian cancer, cervical cancer, and small cell lung cancer.
Tyrosine Kinase Inhibitors
Imatinib : Tablets for the treatment of chronic myeloid leukemia (CML), Philadelphia chromosome acute lymphoblastic leukemia (ALL).
Erlotinib : Tablets for the treatment of EGFR-mutated non-small cell lung cancer and pancreatic cancer.
Gefitinib : Tablets for the treatment of EGFR-mutated non-small cell lung cancer.
Sorafenib : Tablets for the treatment of hepatocellular carcinoma, advanced kidney cancer, and differentiated thyroid cancer resistant to radioactive iodine.
Sunitinib : Capsules for the treatment of advanced kidney cancer, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
Monoclonal Antibodies
Trastuzumab : Injectable for the treatment of breast and gastric cancer with overexpression of the HER2 receptor.
Rituximab : Injectable for the treatment of non-Hodgkin lymphomas, chronic lymphocytic leukemia (CLL).
Bevacizumab : Injectable for the treatment of metastatic colorectal cancer and non-small cell lung cancer.
Cetuximab : Injectable for the treatment of metastatic colorectal cancer and head and neck cancer